Mon, Jul 14, 2014, 8:16 AM EDT - U.S. Markets open in 1 hr 14 mins

Recent

% | $
Quotes you view appear here for quick access.

Amicus Therapeutics, Inc. (FOLD) Message Board

  • alabamatigers11u alabamatigers11u Dec 19, 2012 6:01 PM Flag

    Amicus said it expects to report results from 12 months of treatment in the first half of 2013, after which it plans to meet with the FDA to discuss a U.S. "approval pathway."

    Amicus said it expects to report results from 12 months of treatment in the first half of 2013, after which it plans to meet with the FDA to discuss a U.S. "approval pathway."

    i believe FOLD will rise after the CC, looks like all hope is not lost?? We'll see.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • FDA could approve this drug or not. It means nothing for shareholders as there is no substantial market for this drug. FOLD got a pipeline of drugs which can not be commercially viable no matter how much they would charge for treatment $5, $50 or $500

 
FOLD
3.96+0.10(+2.59%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.